OSE Immunotherapeutics S.A.

OSE.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income€0-€0-€0-€0
Dep. & Amort.€0€0€0€0
Deferred Tax€0-€0-€0-€0
Stock-Based Comp.€0€0€0€0
Change in WC€0-€0-€0€0
Other Non-Cash€0-€0-€0-€0
Operating Cash Flow€0-€0-€0-€0
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases-€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.-€0-€0€0-€0
Investing Cash Flow-€0-€0€0-€0
Financing Activities
Debt Repay.-€0€0€0€0
Stock Issued€0€0€0€0
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0-€0-€0-€0
Financing Cash Flow-€0€0€0€0
Forex Effect€0-€0€0€0
Net Chg. in Cash-€0-€0-€0€0
Supplemental Information
Beg. Cash€0€0€0€0
End Cash€0€0€0€0
Free Cash Flow€0-€0-€0-€0